KLF13 and hematopoietic and lymphoid system neoplasm: The expression of KLF9 and KLF13 in tumor-associated immune cells and tumor stroma, coupled with the known biology of these proteins in circulating immune cells, makes a strong case for focusing on the functions of these two KLFs in the tumor microenvironment of solid tumors and blood cancers.